Global Osteoporosis Treatment Market Treatment Market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.
Market Outline: Osteoporosis Treatment Market
Osteoporosis is commonly occurred bone disease which thins and weakens the bones. Bone become brittle and break easily and especially bones in spine, wrist and hips. There are several factors may cause this condition which include genetic history, low intake of calcium, lack of vitamin D and others. Moreover conditions such as inactivity and immobility, anorexia and diseases such as cancer, chronic kidney diseases may cause the osteoporotic condition. The patients with osteoporosis have increased risk for the fractures due to loss in bone strength. The condition is primarily treatment may include, vitamin D, exercise and osteoporosis medication.
Market Dynamics: Osteoporosis Treatment Market
Global osteoporosis treatment market primarily driven by rise in prevalence of the osteoporosis and obese patients around the world. According to International Osteoporosis Foundation, about 200 million people were diagnosed with the osteoporosis around the world. In addition, rise in research and development investments in development of drugs, innovative pipeline therapies such as monoclonal antibodies expected to boost the market growth over the forecast period. Furthermore, rise in prevalence of the disease in post-menopausal woman, rise in awareness about the disease symptoms, ageing population expected to bolster the market share. However, the side effects of the osteoporosis drugs, high cost of drug discovery and development projected to hamper the market growth over the forecast period.
Market Scope: Osteoporosis Treatment Market
Global osteoporosis treatment market is segmented based on the type, application, end user and geography
Based on therapy type, the market is segmented into the following:
- Drug therapy
- Hormonal Therapy
- Parathyroid Hormone
- Selective Estrogen Receptor Modulators
Based on distribution channel, market is segmented into following:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Based on region, Market is segmented into
- North America
- Latin America
- Asia Pacific
- Middle East and Africa (MEA)
Regional Analysis: Osteoporosis Treatment Market
Geographically, global osteoporosis treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America osteoporosis treatment market expected to grow at significant rates owing to the rise in prevalence of osteoporosis and obesity, sedentary lifestyle, and recent product launches by market players. According to National Osteoporosis Foundation, about 54 million people are diagnosed with the osteoporosis in 2016. Europe osteoporosis treatment market expected to grow at notable rates owing to the rise in geriatric population, increase in R&D investments, recent product launches and rise in prevalence of osteoporosis. Asia Pacific osteoporosis treatment market anticipated to project lucrative market growth over forecast period owing to the rise in demand for the bone cell therapies, presence of the pool of patients and presence of active pipeline drugs for the treat osteoporosis.
Competition Assessment: Osteoporosis Treatment Market
Some of the players in the global osteoporosis treatment market include:
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S.)
- Hoffmann-La Roche AG (Switzerland)
- Eli Lilly and Company (U.S.)
- Teva Pharmaceutical Industries (Denmark)
- Novo Nordisk (Denmark)
- Cipla (India)
- Allergan plc (Ireland)
- Radius Health (U.S.)
Notable Market Developments: Osteoporosis Treatment Market
- In April 2017, U.S. Food and Drug Administration has approved Radius Health’s bone building agent tymlos (abaloparatide) for treatment of osteoporosis.